Luis F. Voloch is an AI researcher, entrepreneur, and lecturer at Stanford Graduate School of Business, where he teaches about management and entrepreneurship topics in data science and AI heavy companies, and where they differ from traditional software companies. Luis is the cofounder of Immunai, an AI-driven cancer immunotherapy biotech company based out of NYC. They develop cutting edge technologies at the intersection of AI, genomics, big data, and immunology for developing immunotherapies. Immunai has over 140 people in NYC and other sites, and have raised over $300M and are valued at over $1B.